Medikarudetabijon

3902.TTSE PRIME

Filed as Medical Data Vision Co.,Ltd. (2022-08–2026-03)

Key numbers · FY ended 2025-12

Revenue¥6.5bn+10.7% YoY Operating income¥349m+9181.9% YoY Net income (owners)¥280m—Total assets¥4.8bn+0.6% YoY EPS (basic)¥7.4+135.7% YoY

Full financial history and reports →

Stock price3902 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Feb 20 · JST1 filing

15:395% STAKEMedikarudetabijon · Goldman Sachs International + 2 joint holders · 5.62% → 0.18%−5.44pp

Thu, Feb 19 · JST1 filing

11:435% STAKEMedikarudetabijon · Nomura Asset Management Co., Ltd. + 2 joint holders · 5.22% → 1.82%−3.40pp

Tue, Feb 10 · JST1 filing

15:515% STAKEMedikarudetabijon · SBI Holdings, Inc. + 1 joint holder · 36.24% → 86.41%+50.17pp

Mon, Feb 9 · JST2 filings

15:45MATERIALMedical Data Vision · Event with a material impact on financial position 15:015% STAKEMedical Data Vision · NIPPON LIFE INSURANCE COMPANY + 1 joint holder · 86.41%new 86.41%

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
Nippon Life Insurance Companyjoint holder	50.17%	0.00pp	2026-02-10
SBI Holdings, Inc.	36.24%	0.00pp	2026-02-10

Each holder's own ratio from its most recent large-shareholding report.